Endocrine Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of ENDOCRINE TODAY.

Table of Contents
5 Questions

A conversation with pediatric obesity researcher Denise Wilfley, PhD

Cover Story

New treatments, advances changing outcomes for radioactive iodine-refractory thyroid cancer

Diabetes in Real Life

Guidance needed for dietary supplement use in diabetes

In the Journals

Omega-3s may provide no cardiovascular health benefit

In the Journals Plus

Thyroid storm substantially increases hospital mortality

Prenatal drug exposure may influence stress response, obesity risk in teen girls

Parental monitoring can positively affect adolescent weight status

No urinary tract infection risk with most SGLT2 inhibitors

No association between long-term GH replacement, comorbidities in nonfunctioning pituitary adenoma

Metformin fails to improve birth outcomes in pregnancy with obesity

Low-carb diets show promise in improving glycemic measures

Long-term follow-up needed after gamma knife radiosurgery for acromegaly

Interventions for couples yield benefits for partners of adults with type 2 diabetes

Insulin glargine, lixisenatide combination safe, effective for older adults with type 2 diabetes

Influence of HbA1c on fracture risk differs in type 1, type 2 diabetes

Hormonal contraception may cause bone loss in adolescent girls

Gelesis100 shows promise for weight loss in adults with obesity

Cost, expected weight loss primary factors in opting for bariatric surgery

Autoimmune thyroid disease, retinopathy may signal Addison’s disease in type 1 diabetes

Type 2 diabetes may cause erectile dysfunction

Meeting News

VIDEO: Sleep plays key role in cardiometabolic health

Point/Counter

Should lenvatinib or sorafenib be the first agent used in slowly progressing radioiodine-refractory thyroid carcinoma?